ATE222366T1 - Immunohistochemischer nachweis des proliferativen zustandes von karzinoma - Google Patents

Immunohistochemischer nachweis des proliferativen zustandes von karzinoma

Info

Publication number
ATE222366T1
ATE222366T1 AT97952197T AT97952197T ATE222366T1 AT E222366 T1 ATE222366 T1 AT E222366T1 AT 97952197 T AT97952197 T AT 97952197T AT 97952197 T AT97952197 T AT 97952197T AT E222366 T1 ATE222366 T1 AT E222366T1
Authority
AT
Austria
Prior art keywords
carcinoma
sample
immunohistochemical detection
proliferative state
expression product
Prior art date
Application number
AT97952197T
Other languages
English (en)
Inventor
Michael N Gould
Steven P Stoesz
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE222366T1 publication Critical patent/ATE222366T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97952197T 1997-01-06 1997-11-18 Immunohistochemischer nachweis des proliferativen zustandes von karzinoma ATE222366T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/779,870 US5846739A (en) 1995-12-05 1997-01-06 Immunohistochemical detection assay for carcinoma proliferative status
PCT/US1997/020998 WO1998030907A1 (en) 1997-01-06 1997-11-18 Immunohistochemical detection assay for carcinoma proliferative status

Publications (1)

Publication Number Publication Date
ATE222366T1 true ATE222366T1 (de) 2002-08-15

Family

ID=25117836

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97952197T ATE222366T1 (de) 1997-01-06 1997-11-18 Immunohistochemischer nachweis des proliferativen zustandes von karzinoma

Country Status (12)

Country Link
US (1) US5846739A (de)
EP (1) EP0958500B1 (de)
JP (1) JP3336016B2 (de)
AT (1) ATE222366T1 (de)
AU (1) AU712949B2 (de)
CA (1) CA2271092C (de)
DE (1) DE69714778T2 (de)
DK (1) DK0958500T3 (de)
ES (1) ES2182140T3 (de)
IL (1) IL129766A (de)
NZ (1) NZ335535A (de)
WO (1) WO1998030907A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6517513B1 (en) * 1999-01-21 2003-02-11 Neomatrix, Llc Intraductal breast fluid aspiration device
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
RU2276672C2 (ru) * 2000-04-10 2006-05-20 Институт Биоорганической химии им. акад. М.М. Шемякина и Ю.А. Овчинникова Российской Академии Наук Антитело к фактору hldf, способ его получения (варианты), пептид с антигенными и нк-гидролизующими свойствами и способ диагностики анапластического состояния клетки человека
WO2001077682A1 (fr) * 2000-04-10 2001-10-18 Institut Bioorganicheskoi Khimii Imeni Akademikov M.M. Shemyakina I Ju. A. Ovchinnikova Rossiisskoi Akademii Nauk Anticorps diriges contre le facteur hldf, procedes de fabrication correspondants, peptides avec des capacites antigeniques et a hydrolyse hk et procede de diagnostic de l'etat anaplasique de cellules humaines
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
DE10230631A1 (de) * 2002-07-02 2004-01-22 Metagen Pharmaceuticals Gmbh Verwendungen von an Ngal bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen
DE602006012816D1 (de) * 2005-03-30 2010-04-22 Endocyte Inc Tifizierung von zellulären folat vitamin rezeptoren
US20100105150A1 (en) * 2008-10-24 2010-04-29 Abbott Laboratories Isolated human autoantibodies to neutrophil gelatinase-associated lipocalin (ngal) and methods and kits for the detection of human autoantibodies to ngal
WO2010054025A1 (en) * 2008-11-05 2010-05-14 Abbott Laboratories Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, and methods of enrichment, analysis and use
EP2710041A4 (de) 2011-05-18 2014-11-05 Parkinson S Inst Assay zur bestimmung der lrrk2-aktivität bei morbus parkinson

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996024065A1 (en) * 1995-02-03 1996-08-08 Oncogene Science, Inc. Methods for the detection of pro-cathepsins and uses thereof
US5627034A (en) * 1995-12-05 1997-05-06 Wisconsin Alumni Research Foundation Assay for carcinoma proliferative status by measuring NGAL expression level

Also Published As

Publication number Publication date
NZ335535A (en) 2000-08-25
IL129766A0 (en) 2000-02-29
ES2182140T3 (es) 2003-03-01
CA2271092A1 (en) 1998-07-16
IL129766A (en) 2002-02-10
JP2000508074A (ja) 2000-06-27
DK0958500T3 (da) 2002-10-07
US5846739A (en) 1998-12-08
DE69714778T2 (de) 2003-04-10
WO1998030907A1 (en) 1998-07-16
EP0958500B1 (de) 2002-08-14
DE69714778D1 (de) 2002-09-19
JP3336016B2 (ja) 2002-10-21
EP0958500A1 (de) 1999-11-24
AU712949B2 (en) 1999-11-18
AU5586798A (en) 1998-08-03
CA2271092C (en) 2004-02-10

Similar Documents

Publication Publication Date Title
ATE406834T1 (de) System zur überwachung der konzentration von analyten in körperflüssigkeiten
DE69928809D1 (de) Differentielle diagnose von neurodegeneration
ATE372389T1 (de) Regeneration von biosensoren
NO20010011L (no) Optisk sensor for in-situ-måling av analytter
BR0306588A (pt) Biosensor possuindo eletrodo para determinar a taxa de fluxo de um fluido
CA2530052A1 (en) System and method for analyte measurement using dose sufficiency electrodes
IL172997A0 (en) Device and method for simultaneous carrying out of blood group determination, serum cross-check and antibody detection test
ATE449865T1 (de) Teststreifen zum analytnachweis und verwendungsverfahren
DE50209636D1 (de) Messvorrichtung und -verfahren zur Bestimmung von Parametern medizinischer Flüssigkeiten
BR9507690A (pt) Detecção de reticulócitos
DE69330067D1 (de) Analytische testvorrichtung einschliesslich negativ- und positivkontrolle
ES549895A0 (es) Procedimiento para detectar y determinar un analito con pro-piedades de fijacion bioafines en una muestra liquida
ATE245937T1 (de) Überwachung physiologischer analyte
WO2002057787A3 (en) Detection of survivin in the biological fluids of cancer patients
ATE267399T1 (de) Verfahren zum nachweis von komplex-gebundenem prostata-spezifischem antigen (kpsa)
DE69714778D1 (de) Immunohistochemischer nachweis des proliferativen zustandes von karzinoma
EP1563308A4 (de) Verfahren und kits zur tumorigenizitätsdiagnose
ATE403012T1 (de) Schnelle quantitative messung von löslichem fibrin in opaken körperflüssigkeiten
WO2000026668A3 (en) S100 proteins and autoantibodies as serum markers for cancer
DE69636749D1 (de) Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten
DE50104561D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
NO953770L (no) Analysemetode
ATE333091T1 (de) Verfahren zur messung von blutersatzstoffen
TW369411B (en) Disposal electrode test block for current-type non-enzymatic uric acid test, its process and application
ES501364A0 (es) Procedimiento para la deteccion y determinacion de monomero de fibrina en liquidos biologicos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties